$0.6500
-0.005-0.76%
Last update: Nov 4, 6:36 AM
Dare Bioscience Inc (DARE) Stock Price, Quote, News & History
DARENASDAQ
Dare Bioscience stock climbed after Phase 3 interim data for Ovaprene showed expected pregnancy rates and no trial changes by DSMB.
You can purchase shares of Dare Bioscience (NASDAQ:DARE) through any online brokerage.
Other companies in Dare Bioscience’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Dare Bioscience has a consensus price target of $14.20.
The stock price for Dare Bioscience (NASDAQ: DARE) is $0.7 last updated November 4, 2026 at 6:36 AM EST.
There are no upcoming dividends for Dare Bioscience.
Dare Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Dare Bioscience.
Dare Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and...
